Diabetic retinopathy (DR) is both the leading cause of blindness among adults aged 20 to
74 in the United States, and the leading ocular complication associated with diabetes …

Diabetes mellitus (DM) is a rapidly growing epidemic in the United States, and it is expected
to affect 592 million individuals within the next 20 years. Diabetic retinopathy (DR) and …

Diabetic retinopathy is the leading cause of blindness in persons under age 60 in the United
States, and diabetic macular edema (DME) is the most common cause of visual loss in those …

Diabetic retinopathy (DR) is a leading cause of preventable blindness world-wide. Diabetic
macular edema (DME) is the most common cause of moderate vision loss in patients with …

There are an estimated 18 million individuals in the United States afflicted with diabetes
mellitus and approximately 4% have diabetic macular edema (DME)[1]. This translates to …

Purpose To evaluate how the monitoring and treatment for diabetic macular edema (DME)
has changed in a national sample. Design Retrospective cohort study. Methods Setting …

Diabetes is a growing worldwide epidemic and a leading cause of blindness in working-age
people around the world. Diabetic retinopathy (DR) and diabetic macular edema (DME) are …

Diabetic retinopathy (DR) is a leading cause of adult blindness in the United States and
abroad. A recent global analysis suggested that DR affects~ 22% of all patients with …

The diabetes epidemic continues unabated, and it has become an urgent societal problem
requiring global attention. According to a study by the World Health Organization, the …

Purpose To assess how patient choices (out-of-pocket costs, insurance plan, geographic
region) impact initiation of therapy for diabetic macular edema (DME). Design Retrospective …